Literature DB >> 10964863

Differentiating primary from secondary negative symptoms in schizophrenia: a study of neuroleptic-naive patients before and after treatment.

V Peralta1, M J Cuesta, A Martinez-Larrea, J F Serrano.   

Abstract

OBJECTIVE: The study examined the primary versus secondary character of negative symptoms in a group of first-episode, neuroleptic-naive psychotic patients before and after they started neuroleptic treatment.
METHOD: Forty-seven inpatients with a first episode of schizophrenia or related psychotic disorders were examined for the presence of negative symptoms, psychosis, depression, and parkinsonism at admission to an inpatient psychiatric unit, before receiving neuroleptics, and at discharge an average 3.3 weeks later, after starting neuroleptic treatment.
RESULTS: Although patients' mean scores on measures of positive, negative, and depressive symptoms decreased significantly over the treatment period, the mean rating of nonakinetic parkinsonism worsened. The mean rating of akinetic parkinsonism did not change significantly over the treatment period. Negative symptoms at admission were not predicted by positive or depressive symptoms at admission. Residual negative symptoms at discharge were mainly predicted by negative symptoms at admission (i.e., primary symptoms) and to a negligible degree by residual positive and depressive symptoms. Change in negative symptoms over the observation period was predicted to a marginal degree by change in depressive symptoms.
CONCLUSIONS: Negative symptoms rated during a first psychotic episode before and after starting antipsychotic treatment are mainly primary in character and should be considered as a direct manifestation of the basic dysfunctions of schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10964863     DOI: 10.1176/appi.ajp.157.9.1461

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  20 in total

1.  Cognitive behavioural treatment of negative symptoms in schizophrenia patients: study design of the TONES study, feasibility and safety of treatment.

Authors:  Stefan Klingberg; Andreas Wittorf; Jutta Herrlich; Georg Wiedemann; Christoph Meisner; Gerhard Buchkremer; Nicole Frommann; Wolfgang Wölwer
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-11       Impact factor: 5.270

2.  Characterization of spontaneous Parkinsonism in drug-naive patients with nonaffective psychotic disorders.

Authors:  Victor Peralta; Virginia Basterra; Maria S Campos; Elena García de Jalón; Lucía Moreno-Izco; Manuel J Cuesta
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-05-28       Impact factor: 5.270

3.  Antipsychotics and amotivation.

Authors:  Gagan Fervaha; Hiroyoshi Takeuchi; Jimmy Lee; George Foussias; Paul J Fletcher; Ofer Agid; Gary Remington
Journal:  Neuropsychopharmacology       Date:  2015-01-08       Impact factor: 7.853

4.  Ventral striatal hypoactivation is associated with apathy but not diminished expression in patients with schizophrenia.

Authors:  Matthias Kirschner; Oliver M Hager; Martin Bischof; Matthias N Hartmann; Agne Kluge; Erich Seifritz; Philippe N Tobler; Stefan Kaiser
Journal:  J Psychiatry Neurosci       Date:  2016-04       Impact factor: 6.186

Review 5.  Management of negative symptoms of schizophrenia.

Authors:  D C Javitt
Journal:  Curr Psychiatry Rep       Date:  2001-10       Impact factor: 5.285

6.  Concordance between chart review and structured interview assessments of schizophrenic symptoms.

Authors:  Ayman H Fanous; Richard L Amdur; Francis A O'Neill; Dermot Walsh; Kenneth S Kendler
Journal:  Compr Psychiatry       Date:  2011-06-12       Impact factor: 3.735

7.  Spontaneous parkinsonism is associated with cognitive impairment in antipsychotic-naive patients with first-episode psychosis: a 6-month follow-up study.

Authors:  Manuel J Cuesta; Ana M Sánchez-Torres; Elena García de Jalón; Maria S Campos; Berta Ibáñez; Lucía Moreno-Izco; Víctor Peralta
Journal:  Schizophr Bull       Date:  2013-09-26       Impact factor: 9.306

8.  Lack of association between dopaminergic antagonism and negative symptoms in schizophrenia: a positron emission tomography dopamine D2/3 receptor occupancy study.

Authors:  Gagan Fervaha; Fernando Caravaggio; David C Mamo; Benoit H Mulsant; Bruce G Pollock; Shinichiro Nakajima; Philip Gerretsen; Tarek K Rajji; Wanna Mar; Yusuke Iwata; Eric Plitman; Jun Ku Chung; Gary Remington; Ariel Graff-Guerrero
Journal:  Psychopharmacology (Berl)       Date:  2016-08-24       Impact factor: 4.530

9.  Involuntary movements and their correlates in first-episode psychoses.

Authors:  Pallav Pareek; Tejas S Bhojraj; Debra M Montrose; Rajaprabhakaran Rajarethinam; John A Sweeney; Matcheri S Keshavan
Journal:  Acta Neuropsychiatr       Date:  2010-10       Impact factor: 3.403

10.  Dyskinesia and parkinsonism in antipsychotic-naive patients with schizophrenia, first-degree relatives and healthy controls: a meta-analysis.

Authors:  Jeroen P F Koning; Diederik E Tenback; Jim van Os; André Aleman; René S Kahn; Peter N van Harten
Journal:  Schizophr Bull       Date:  2008-11-05       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.